These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8244141)

  • 1. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.
    Clements D; Compston JE; Evans WD; Rhodes J
    Gut; 1993 Nov; 34(11):1543-6. PubMed ID: 8244141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
    Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease.
    Clements D; Motley RJ; Evans WD; Harries AD; Rhodes J; Coles RJ; Compston JE
    Scand J Gastroenterol; 1992 Dec; 27(12):1055-60. PubMed ID: 1475623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone loss in patients with inflammatory bowel disease: a prospective study.
    Roux C; Abitbol V; Chaussade S; Kolta S; Guillemant S; Dougados M; Amor B; Couturier D
    Osteoporos Int; 1995 May; 5(3):156-60. PubMed ID: 7655175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study.
    Sirola J; Kröger H; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S; Honkanen R
    Calcif Tissue Int; 2003 Jun; 72(6):659-65. PubMed ID: 14562993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J; Kröger H; Honkanen R; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S
    Osteoporos Int; 2003 Jan; 14(1):27-33. PubMed ID: 12577182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition.
    Muller ME; Webber CE; Adachi JD
    Can J Physiol Pharmacol; 2003 Oct; 81(10):952-8. PubMed ID: 14608412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone loss in normal British women; a 5 year follow-up.
    Clements D; Compston JE; Evans C; Evans WD
    Br J Radiol; 1993 Dec; 66(792):1134-7. PubMed ID: 8293258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy.
    Going S; Lohman T; Houtkooper L; Metcalfe L; Flint-Wagner H; Blew R; Stanford V; Cussler E; Martin J; Teixeira P; Harris M; Milliken L; Figueroa-Galvez A; Weber J
    Osteoporos Int; 2003 Aug; 14(8):637-43. PubMed ID: 12844212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
    Harris ST; Eriksen EF; Davidson M; Ettinger MP; Moffett AH; Baylink DJ; Crusan CE; Chines AA
    J Clin Endocrinol Metab; 2001 May; 86(5):1890-7. PubMed ID: 11344179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone changes in postmenopausal Thai women with or without hormonal replacement therapy.
    Limpaphayom K; Taechakraichana N; Poshyachinda M; Jaisamrarn U
    J Med Assoc Thai; 1995 Nov; 78(11):573-7. PubMed ID: 8576666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
    Jahnsen J; Falch JA; Aadland E; Mowinckel P
    Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)].
    Gass R; Neff M
    Schweiz Med Wochenschr; 1995 Aug; 125(34):1583-91. PubMed ID: 7569830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.